Well, I'm actually happy mainly because I always have this doubt...

Well,
I'm actually happy mainly because I always have this doubt that management will someday pull a swifty and try to take the company private.

So, we have sales (marginal at the moment) but clinical looks to be drying out and yes, I believe some of this can be put down to Trump. I always thought that clinical sales was the fast track to profitability mostly based on Craig's talk and the initial clinichain contract. Seems like that's been over hyped, so its up to pulse and the retail market to get us there.
I do think there's a market and its big but getting into it will be a war of attrition until we get over the counter sales (I would like an update on that) I would also like to know is other markets than the US will be over counter.
I guess the main reason I'm happy is that Graig is getting the Cap raise underway and not trying to steel the company. The big question is, can he build a sufficient book to get enough capital the secure us to break even. 12000 units is not that much, we are so close. Its obvious they are trying to do it on the cheap, fair play, they haven't a lot of capital to spend on a flashy launch (Thanks to Craigs failed US effort). So its slowly slowly, watch the pennies, pace yourself until OTC happen, then sit back and count the money. Its all about execution, time to step up craig!!! also there better be a Q&A at the general.